ARCHIVES

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

Bush Vetoes HHS Budget Bill, House Votes To Sustain.

November 23, 2007

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

Von Eschenbach Presents His “2015 Goal” As Logical Progression of Cancer Program (Interview)

May 16, 2003

Blayney Elected ASCO President For 2009.

March 7, 2008

NCI Comprehensive Center List Omits Georgetown/Howard, Adds Arizona

June 1, 1990

In Brief: Use More Ad Hoc Committees For Grants, Look At Number, Distribution Of Centeres: Katterhagen

August 28, 1981